Dow Jones Top Company Headlines at 3 PM ET: How Chinese AI Firms Tried to Clone U.S. AI Models | Polymarket ...

Dow Jones
Yesterday

How Chinese AI Firms Tried to Clone U.S. AI Models

Anthropic says DeepSeek and Moonshot used thousands of fake accounts and millions of real user queries in "distillation" efforts to clone its AI capabilities.

----

Polymarket Appoints First Finance Chief Amid U.S. Growth Plans

Warren Jenson, who previously served as finance chief of Amazon, Electronic Arts, Delta Air Lines and NBC during the '90s and early 2000s, has been appointed as Polymarket's first chief financial officer.

----

Boston Scientific Restores Key Operations After Cyberattack

The company said products are moving through its distribution network at or above normal levels as the Marlborough, Mass., company works to fulfill customer orders, reduce backlogs and accelerate the delivery of products.

----

Positron Valued at $5 Billion in New Funding as Demand for AI Chips Surges

NEA, Atreides and Jim Clark are among the investors putting $875 million into the firm, which makes chips designed for fast running of AI models.

----

Macy's Bets on Pricier Products to Win Wealthy Shoppers

The department-store chain raised its full-year outlook Thursday, which executives said was partly driven by higher prices on its products.

----

Designer Brands Boosts Outlook on Positive Start to Current Quarter

The updated forecast came as the footwear-and-accessories company recorded higher profit despite lower sales in the second quarter.

----

JetBlue Cuts Capacity-Growth Outlook, Citing Bad Weather and Fuel Costs

The airline said it expects available seat miles to increase 1.5% to 3.5% during the third quarter, versus prior guidance of 3%-to-6% growth.

----

Anthropic Gives EU's Cybersecurity Agency Access to Mythos 5 AI Model

The EU Commission had been in talks for months with the company, whose Mythos 5 model can spot vulnerabilities in computer code and sparked national security concerns.

----

Chemours, DuPont and Corteva to Pay $455 Million in North Carolina PFAS Settlement

The companies settled with North Carolina and 11 communities that were excluded from a previous settlement over drinking-water toxins.

----

Brooks Automation Files Confidentially for IPO

Private-equity firm THL owns the company.

----

Mistral to Grow Enterprise Customer Base With Cloudera

Mistral said the partnership would bolster its exposure to clients across regulated industries as they seek increasingly capable AI models to streamline their operations.

----

Cheap Biologic Drug Alternatives Stall, Threatening U.S. Healthcare Savings

A new industry report shows 90% of major brand-name biologic drugs losing exclusivity over the next decade have no low-cost competitors in development.

----

The IPO That Asks You to Buy AI Hype Today and Get Paid Years Later

SB Energy's offering features $430 billion in data-center deals, no operating sites and a clause giving OpenAI free rent for delays.

----

HSBC Begins Search for New Finance Chief as Pam Kaur Departs

Pam Kaur told the group's board of her intention to stand down next year, though the exact date of her departure hasn't been confirmed.

----

Drone Deal Kicks Off Consolidation in Ukraine's 500-Company Industry

An Erik Prince-backed defense technology firm scooped up a Ukrainian maker of unmanned ground vehicles in a tie-up worth $224 million.

 

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10